Immune suppressive treatment in paediatric myocarditis: Still awaiting the evidence

Heart

Volumn 90, Issue 10, 2004, Pages 1103-1104

  Burch, M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; IMMUNOSUPPRESSIVE AGENT; INTERFERON; STEROID; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULATION; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; EDITORIAL; HEART EJECTION FRACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SURVIVAL RATE; VIRUS MYOCARDITIS;

AGE FACTORS; CHILD; HUMANS; IMMUNOSUPPRESSION; MYOCARDITIS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 4644309479     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.034082     Document Type: Editorial

References (23)

1. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators. N Engl J Med 1995;333:269-75.
2. Maisch B, Hufnagel G, Schonian U, et al. The European study of epidemiology and treatment of cardiac inflammatory disease (ESETCID). Eur Heart J 1995;16(suppl O):173-5.
3. Maisch B, Herzum M, Hufnagel G, et al. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J 1995;16(suppl O):153-61.
4. Garg A, Shiau J, Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 1998;129:317-22.
5. Ciszewski A, Bilinska ZT, Lubiszewska B, et al. Dilated cardiomyopathy in children: clinical course and prognosis. Pediatr Cardiol 1994;15:121-6.
6. Balaji S, Wiles HB, Sens MA, et al. Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm. Br Heart J 1994;72(4):354-9.
7. Kleinert S, Weitraub RG, Wilkinson JL, et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997;16:1248-54.
8. Ino T, Okubo M, Akimoto K, et al. Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis. J Pediatr 1995;126:304-8.
9. Ahdoot J, Galindo A, Alejos JC, et al. Use of OKT3 for acute myocarditis in infants and children. J Heart Lung Transplant 2000;19:1118-21.
10. Chan KY, Iwahara M, Benson LN, et al. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trail. J Am Coll Cardiol 1991;17:458-60.
11. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999;82:226-33.
12. Camargo PR, Snitcowsky R, da Luz PL, et al. Favourable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995;16:61-8.
13. Giulia Gagliardi M, Bevilacqua M, Bassano C, et al. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004;90:1167-71.
14. McMahon AM, van Doorn C, Burch M, et al. Improved outcome for end stage dilated cardiomyopathy in children. J Thorac Cardiovasc Surg 2003; 126:1781-7.
15. Burch M, Siddiqi SA, Celermajer DE, et al. Dilated cardiomyopathy determinants of outcome. Br Heart J 1994;72:246-50.
16. Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 1988;11:139-44.
17. Tomloko W. Effects of prednisolone in acute viral myocarditis in mice. J Am Coll Cardiol 1986;4:868-72.
18. Shirali GS, Chinnock RE, Johnson JK, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001;344:1498-503.
19. Kuhl U, Pauschinger M, Schwimmbeck P, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with persistence of viral genomes and left ventricular dysfunction. Circulation 2003;107:2793-8.
20. Cooper LT, Berry GJ, Shabetai R. Idopathic giant cell myocarditis: natural history and treatment. N Engl J Med 1997;336:1860-6.
21. Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responaers versus non-responders. Circulation 2003; 107:857-63.
22. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104:1076-82.
23. Gogliardi MG, Bevilacqua M, Squitieri C, et al. Dilated cardiomyopathy caused by acute myocarditis in paediatric patients. J Heart Lung Transplant 1993;12:S224-9.